Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Assets: 2022-2025

Historic Non-Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $4.8 million.

  • Gossamer Bio's Non-Current Assets fell 26.92% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 26.92%. This contributed to the annual value of $5.4 million for FY2024, which is 0.13% up from last year.
  • As of Q3 2025, Gossamer Bio's Non-Current Assets stood at $4.8 million, which was down 3.90% from $5.0 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Non-Current Assets high stood at $13.9 million for Q1 2022, and its period low was $2.5 million during Q2 2024.
  • Over the past 3 years, Gossamer Bio's median Non-Current Assets value was $5.4 million (recorded in 2023), while the average stood at $5.8 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 69.59% in 2024, then surged by 97.52% in 2025.
  • Over the past 4 years, Gossamer Bio's Non-Current Assets (Quarterly) stood at $10.6 million in 2022, then plummeted by 48.94% to $5.4 million in 2023, then climbed by 0.13% to $5.4 million in 2024, then decreased by 26.92% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $5.0 million for Q2 2025, and $5.1 million during Q1 2025.